Skip to content

Clinical trials

Phase 3 Emergence Delirium trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emergence Delirium Phase: Phase 3 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20121
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco2
Beth Israel Deaconess Medical Center1
Icahn School of Medicine at Mount Sinai1
Mayo Clinic1
Peter Davis1
St. Luke's-Roosevelt Hospital Center1
University of Colorado, Denver1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emergence Delirium9
Delirium3
Postoperative Pain3
Cognitive Dysfunction1
Intraoperative Awareness1
Pain1
Postoperative Cognitive Complications1
Postoperative Nausea and Vomiting1
Psychomotor Agitation1
Sleep Disorders, Circadian Rhythm1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.